Tech Company Financing Transactions

StrideBio Funding Round

Northpond Ventures, Novo Ventures and Alexandria Venture Investments participated in a $81.5 million Series B funding round for StrideBio. The round closed on 3/17/2021.

Transaction Overview

Company Name
StrideBio
Announced On
3/17/2021
Transaction Type
Venture Equity
Amount
$81,500,000
Round
Series B
Investors

Northpond Ventures (Lead Investor) (Shaan Gandhi)

Novo Ventures (Lead Investor) (Karen Hong)

Alexandria Venture Investments

CaaS Capital Management

Hatteras Venture Partners (Clay Thorp)

Octagon Investments Fund

Pontifax Fund

Sarepta Therapeutics

Takeda Ventures (Jayson Punwani)

UCB S.A. (Erica Whittaker)

University of Florida

Proceeds Purpose
Funds raised as part of the Series B will be used to support continued operational growth and manufacturing capacity expansion, building on the company's current infrastructure which includes a 6,000 sq ft GMP clean suite.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5 Laboratory Dr. 1200
Research Triangle Park, NC 27709
USA
Phone
984-213-7300
Website
www.stridebio.com
Email Address
[email protected]
Overview
StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies. Our STRucture Inspired DEsign approach holds the potential to generate unique AAV capsids capable of overcoming the challenges of pre-existing neutralizing antibodies in patients.
Profile
StrideBio LinkedIn Company Profile
Social Media
StrideBio Company Twitter Account
Company News
StrideBio News
Facebook
StrideBio on Facebook
YouTube
StrideBio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sapan Shah
  Sapan Shah LinkedIn Profile  Sapan Shah Twitter Account  Sapan Shah News  Sapan Shah on Facebook
Chief Operating Officer
William Monteith
  William Monteith LinkedIn Profile  William Monteith Twitter Account  William Monteith News  William Monteith on Facebook
Chief Scientific Officer
Aravind Asokan
  Aravind Asokan LinkedIn Profile  Aravind Asokan Twitter Account  Aravind Asokan News  Aravind Asokan on Facebook
Co-Founder
Mavis Agbandje
  Mavis Agbandje LinkedIn Profile  Mavis Agbandje Twitter Account  Mavis Agbandje News  Mavis Agbandje on Facebook
Co-Founder
Patrick Ritschel
  Patrick Ritschel LinkedIn Profile  Patrick Ritschel Twitter Account  Patrick Ritschel News  Patrick Ritschel on Facebook
VP - Bus. Development
Maritza McIntyre
  Maritza McIntyre LinkedIn Profile  Maritza McIntyre Twitter Account  Maritza McIntyre News  Maritza McIntyre on Facebook
VP - Finance
Robert Hughes
  Robert Hughes LinkedIn Profile  Robert Hughes Twitter Account  Robert Hughes News  Robert Hughes on Facebook
VP - Operations
Ariane Hamaide
  Ariane Hamaide LinkedIn Profile  Ariane Hamaide Twitter Account  Ariane Hamaide News  Ariane Hamaide on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/17/2021: Acepodia venture capital transaction
Next: 3/17/2021: Iridia venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.